Skip to main content
Clinical Trials/NCT00598117
NCT00598117
Completed
Not Applicable

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

Memorial Sloan Kettering Cancer Center1 site in 1 country409 target enrollmentAugust 2003

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
409
Locations
1
Primary Endpoint
To prospectively evaluate the quality of life of patients before and after esophageal cancer resection.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.

Detailed Description

In order to determine the impact of esophageal cancer and its treatment on patients' quality of life over time, this study will prospectively follow a cohort of patients at specified intervals, evaluating their physical symptoms, physical and social functioning and overall quality of life. Medical and sociodemographic factors as well as health behaviors that might be predictive of adaptation will be tested. This is a preliminary investigation and it is hoped that we will be able to base future research questions on the results of this study.

Registry
clinicaltrials.gov
Start Date
August 2003
End Date
June 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Diagnosis of esophageal cancer.
  • Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal, McKeown procedure) of esophageal cancer. (Group 1 patients only)
  • Underwent esophagectomy for esophageal cancer at least 18 months prior to consent, with no evidence of disease. (Group 2 patients only)
  • Ability to speak, read and write English.

Exclusion Criteria

  • Inability to give informed consent.
  • Patients anticipated to require a laryngectomy as part of their surgical resection.

Outcomes

Primary Outcomes

To prospectively evaluate the quality of life of patients before and after esophageal cancer resection.

Time Frame: Initial assessment → first post op visit → 6 and 12 months post surgery

Secondary Outcomes

  • To describe a cohort of long term survivors of esophageal cancer in order to identify significant features in patients more than 18 months post surgery.(18 months following treatment)

Study Sites (1)

Loading locations...

Similar Trials